$0.40 Earnings Per Share Expected for Medical Properties Trust, Inc. (NYSE:MPW) This Quarter

Analysts forecast that Medical Properties Trust, Inc. (NYSE:MPW) will announce earnings of $0.40 per share for the current quarter, Zacks reports. Six analysts have issued estimates for Medical Properties Trust’s earnings, with the lowest EPS estimate coming in at $0.38 and the highest estimate coming in at $0.42. Medical Properties Trust reported earnings per share of $0.31 during the same quarter last year, which would suggest a positive year over year growth rate of 29%. The business is scheduled to report its next quarterly earnings results on Thursday, May 7th.

According to Zacks, analysts expect that Medical Properties Trust will report full year earnings of $1.65 per share for the current fiscal year, with EPS estimates ranging from $1.61 to $1.70. For the next fiscal year, analysts forecast that the business will post earnings of $1.72 per share, with EPS estimates ranging from $1.66 to $1.78. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side analysts that that provide coverage for Medical Properties Trust.

Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings results on Thursday, February 6th. The real estate investment trust reported $0.26 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.35 by ($0.09). The company had revenue of $256.44 million for the quarter, compared to analyst estimates of $263.35 million. Medical Properties Trust had a net margin of 43.86% and a return on equity of 6.57%. Medical Properties Trust’s revenue was up 42.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.31 earnings per share.

A number of research analysts have recently weighed in on MPW shares. TheStreet upgraded Medical Properties Trust from a “c+” rating to a “b” rating in a research report on Thursday, February 6th. Barclays reissued a “buy” rating and issued a $22.00 price objective on shares of Medical Properties Trust in a research note on Wednesday, March 18th. Zacks Investment Research downgraded shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a report on Wednesday, March 11th. Bank of America upgraded shares of Medical Properties Trust from a “neutral” rating to a “buy” rating in a report on Monday. Finally, Mizuho lifted their target price on shares of Medical Properties Trust from $25.00 to $26.00 and gave the stock a “buy” rating in a research report on Thursday, December 26th. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the stock. Medical Properties Trust presently has a consensus rating of “Buy” and an average target price of $21.88.

MPW opened at $15.93 on Monday. The business’s fifty day moving average is $20.85 and its two-hundred day moving average is $20.55. The company has a debt-to-equity ratio of 1.00, a quick ratio of 9.45 and a current ratio of 9.45. The company has a market cap of $7.41 billion, a price-to-earnings ratio of 18.52, a PEG ratio of 1.55 and a beta of 0.62. Medical Properties Trust has a one year low of $12.35 and a one year high of $24.29.

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 9th. Investors of record on Thursday, March 12th will be paid a $0.27 dividend. This is an increase from Medical Properties Trust’s previous quarterly dividend of $0.26. The ex-dividend date of this dividend is Wednesday, March 11th. This represents a $1.08 annualized dividend and a yield of 6.78%. Medical Properties Trust’s payout ratio is presently 83.08%.

In other Medical Properties Trust news, COO Emmett E. Mclean sold 100,000 shares of the firm’s stock in a transaction dated Wednesday, January 8th. The shares were sold at an average price of $20.84, for a total transaction of $2,084,000.00. Following the sale, the chief operating officer now directly owns 1,003,415 shares of the company’s stock, valued at approximately $20,911,168.60. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.18% of the stock is currently owned by corporate insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Total Clarity Wealth Management Inc. acquired a new stake in Medical Properties Trust during the fourth quarter worth approximately $25,000. Orion Portfolio Solutions LLC purchased a new position in shares of Medical Properties Trust during the 4th quarter worth $30,000. Arlington Partners LLC purchased a new position in shares of Medical Properties Trust during the 4th quarter worth $32,000. Archer Investment Corp acquired a new stake in shares of Medical Properties Trust during the fourth quarter worth $34,000. Finally, Manchester Financial Inc. acquired a new stake in shares of Medical Properties Trust during the fourth quarter worth $40,000. Institutional investors and hedge funds own 84.22% of the company’s stock.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Featured Article: Put Option Volume

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.